MASSETTI, Anna Paola
 Distribuzione geografica
Continente #
NA - Nord America 3.964
EU - Europa 1.277
AS - Asia 703
SA - Sud America 40
AF - Africa 28
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.022
Nazione #
US - Stati Uniti d'America 3.896
IT - Italia 442
IN - India 230
SG - Singapore 228
SE - Svezia 216
CN - Cina 149
UA - Ucraina 122
FI - Finlandia 119
DE - Germania 88
RO - Romania 80
IE - Irlanda 66
CA - Canada 60
GB - Regno Unito 45
AR - Argentina 32
MY - Malesia 32
TR - Turchia 21
BG - Bulgaria 20
NL - Olanda 15
BE - Belgio 13
FR - Francia 11
LU - Lussemburgo 9
TG - Togo 9
AU - Australia 7
EG - Egitto 7
KR - Corea 7
PH - Filippine 7
AT - Austria 6
JP - Giappone 6
BR - Brasile 5
GE - Georgia 5
GR - Grecia 5
MX - Messico 5
PT - Portogallo 5
BZ - Belize 3
CH - Svizzera 3
IR - Iran 3
PK - Pakistan 3
RU - Federazione Russa 3
SA - Arabia Saudita 3
SC - Seychelles 3
CO - Colombia 2
ES - Italia 2
ID - Indonesia 2
LY - Libia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
VN - Vietnam 2
ZA - Sudafrica 2
BD - Bangladesh 1
BJ - Benin 1
CL - Cile 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
EU - Europa 1
IL - Israele 1
IQ - Iraq 1
IS - Islanda 1
KG - Kirghizistan 1
LT - Lituania 1
LV - Lettonia 1
MA - Marocco 1
MK - Macedonia 1
MU - Mauritius 1
TH - Thailandia 1
TN - Tunisia 1
Totale 6.022
Città #
Fairfield 570
Chandler 301
Ashburn 287
Woodbridge 270
Houston 248
Seattle 235
Wilmington 228
Dearborn 217
Cambridge 197
Rome 174
Singapore 141
Princeton 132
Ann Arbor 131
Plano 102
San Paolo di Civitate 92
Lawrence 75
Horia 70
Dublin 65
Millbury 65
Beijing 64
Jacksonville 49
San Diego 47
Fremont 38
Boston 37
Ottawa 35
Boardman 32
Federal 31
Helsinki 28
Andover 24
Norwalk 24
Falls Church 23
Milan 23
Santa Clara 21
Sofia 20
Toronto 20
New York 19
Nanjing 15
Des Moines 14
Istanbul 14
Brussels 13
Mannheim 12
Bremen 10
Solbiate Olona 10
Lomé 9
London 9
Hefei 8
Kunming 8
Sassoferrato 8
Braunschweig 7
Cairo 7
Guangzhou 7
Nanchang 7
Sydney 7
Dallas 6
Munich 6
Naples 6
Bühl 5
Chicago 5
Durham 5
Falkenstein 5
Jinan 5
Modena 5
Pune 5
Sacramento 5
San Mateo 5
Tbilisi 5
American Fork 4
Amsterdam 4
Ankara 4
Bielefeld 4
Brunn am Gebirge 4
Hebei 4
Iloilo City 4
Phoenix 4
San Jose 4
Shenyang 4
Tappahannock 4
Washington 4
Araraquara 3
Auburn Hills 3
Baltimore 3
Belize City 3
Bern 3
Catania 3
Grafing 3
Hoheneggelsen 3
Indiana 3
Jaipur 3
Lahore 3
Latina 3
Lawrenceburg 3
Prato 3
San Francisco 3
Southwark 3
Stendal 3
Thiene 3
Tokyo 3
Urdaneta 3
Waltham Forest 3
Woodland Hills 3
Totale 4.482
Nome #
The neutrophil/lymphocyte ratio as a prognostic factor in COVID-19 patients: a case-control study 195
Somatization and traumatic events in asylum seekers and refugees resettled in Italy 157
Emergency Department as an epidemiological observatory of Human Mobility. The case of Rome Metropolitan Area (EMAHM). A descriptive analysis of the visits to the ED of the Northern African population 152
A Seven-Year Prospective Study on Spondylodiscitis: Epidemiological and Microbiological Features 100
"Autoantibodies against ganglioside GM3 represent a portion of antilymphocyte antibodies in AIDS patients”. 97
Emergency Department as an epidemiological observatory of Human Mobility: the experience of the Moroccan population 96
Amniocentesis and chorionic villus sampling in HIV-infected pregnant women: a multicentre case series 94
Mutational resistance pattern of HIV type 1 in CD14+ monocytes, CD4+ T cells, and plasma from treated patients 87
How are the undocumented migrants in Rome? Assessment of quality of life and its determinants among migrant population 86
Rubella Susceptibility Profile in Pregnant Women with HIV 85
Pregnancy outcomes and cytomegalovirus DNAaemia in HIV-infected pregnant women with CMV 85
Diagnostic performance in active TB of QFT-Plus assay and co-expression of CD25/CD134 in response to new antigens of Mycobacterium tuberculosis 85
Myeloid and lymphoid activation markers in AIDS and non-AIDS presenters 85
Body Mass Index and Weight Gain in Pregnant Women With HIV: A National Study in Italy 82
Primary retroperitoneal abscesses due to Rhodococcus equi in a patient with severe nephrotic syndrome: successful antibiotic treatment with linezolid and tigecycline 81
Central role of interleukin-15 in human immunodeficiency virus (HIV)-infected patients with visceral leishmaniasis. 80
Changes in circulating levels of soluble cell adhesion molecules following highly active antiretroviral treatment of HIV-1-infected patients 79
Successful conservative treatment of peripheral candidal thrombophlebitis: case report. 79
Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART 79
The synergistic effect of time of exposure, distance and no use of personal protective equipment in the determination of SARS-CoV-2 infection: Results of a contact tracing follow-up study in healthcareworkers 78
Anosmia and ageusia as predictive signs of COVID-19 in healthcare workers in Italy. A prospective case-control study 77
Atazanavir and lopinavir profile in pregnant women with HIV: tolerability, activity and pregnancy outcomes in an observational national study 76
Antiretroviral treatment in pregnancy: A six-year perspective on recent trends in prescription patterns, viral load suppression, and pregnancy outcomes 75
Atypical localization of leishmaniasis in an intestinal polyp 73
Increased carotid intima media thickness is associated with depletion of circulating myeloid dendritic cells in HIV-infected patients on suppressive antiretroviral treatment. 73
Rate, predictors, and consequences of late antenatal booking in a national cohort study of pregnant women with HIV in Italy 72
Plasma lipid profile in pregnant women with HIV receiving nevirapine 72
Circulating dendritic cells and interferon-alpha production in patients with tuberculosis: correlation with clinical outcome and treatment response 72
Switching from protease inhibitors to a single-class regimen of abacavir/lamivudine/zidovudine plus tenofovir in patients with HIV load suppression. 71
Interleukin-15 enhances neutrophil functional activity in patients with human immunodeficiency virus infection 71
Adherence and Genotypic Drug Resistance Mutations in HIV-1-Infected Patients Failing Current Antiretroviral Therapy 71
Neutralizing antibodies against autologous human immunodeficiency virus type 1 isolates in patients with increasing CD4 cell counts despite incomplete virus suppression during antiretroviral treatment 70
Adenosine deaminase activity and acquired immunodeficiency syndrome (AIDS). 70
In vitro effect of anti-human immunodeficiency virus CCR5 antagonist maraviroc on chemotactic activity of monocytes, macrophages and dendritic cells 70
Use of Specific Antiretroviral Regimens Among HIV-Infected Women in Italy at Time of Conception: 2001–2011 69
Treatment change in pregnancy is a significant risk factor for detectable HIV-1 RNA in plasma at end of pregnancy 68
Severe and Persistent Depletion of Circulating Plasmacytoid Dendritic Cells in Patients with 2009 Pandemic H1N1 Infection 68
Good prenatal detection rate of major birth defects in HIV-infected pregnant women in Italy 66
"Overxpression of monosialoganglioside GM3 on lymphoycte plasma membrane in patients with HIV infection". 65
Downregulation of Leukocyte Migration After Treatment With CCR5 Antagonist Maraviroc 65
Clinical features of bacterial meningitis in Italy: a multicenter prospective observational study 64
Chlamydia pneumoniae seroprevalence among HIV-1-infected and uninfected people with known HIV risk factor 63
The role of IL-15 in challenging Acquired Immunodeficiency Syndrome 63
Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011 63
Simplified maintenance therapy with abacavir/lamivudine/zidovudine plus tenofovir after sustained HIV load suppression: Four years of follow-up 62
Ex vivo and in vitro effect of human immunodeficiency virus protease inhibitors on neutrophil apoptosis 62
Protease inhibitor resistance analysis in the MONARK trial comparing first-line lopinavir-ritonavir monotherapy to lopinavir-ritonavir plus zidovudine and lamivudine triple therapy 61
Rate, correlates and outcomes of repeat pregnancy in HIV-infected women 61
Detection of mycobacterial antigen by dot blot assay in the cerebrospinal fluid of patients with tuberculous meningitis. 58
Rate and determinants of treatment response to different antiretroviral combination strategies in subjects presenting at HIV-1 diagnosis with advanced disease 58
QuantiFERON-TB Gold and selected region of difference 1 peptide-based assays for the detection of Mycobacterium tuberculosis infection in a cohort of patients enrolled with suspected tuberculosis 58
Influence of previous tuberculin skin test on serial IFN-γ release assays 58
Plasmacytoid dendritic cells count in antiretroviral-treated patients is predictive of HIV load control independent of CD4+ T-cell count. 58
Voluntary pregnancy termination among women with HIV in the HAART era (2002-2008): A case series from a national study 58
DYSREGULATION OF ADIPOKINES IN HIV-INFECTED PATIENTS UNDER HAART IS A MARKERS FOR CARDIOVASCULAR RISK? 57
Pregnancy outcomes in HIV-infected women of advanced maternal age 57
Human immunodeficiency virus-1 specific and natural cellular immunity in HIV seronegative subjects with multiple sexual exposures to virus 57
SWITCHING TO BOOSTED OR UNBOOSTED ATAZANAVIR IMPROVES GLUCOSE TOLERANCE IN HIV INFECTED SUBJECTS: ATAGLU COHORT STUDY 54
MYELIN DEGRADING ACTIVITY IN THE CSF OF HIV-1-INFECTED PATIENTS WITH NEUROLOGICAL DISEASES 54
The absence of HIV mutations in cerebrospinal fluid and in peripheral blood mononuclear cells during a regimen containing Trizivir plus tenofovir. 54
Association of traumatic events with levels of psychological distress and depressive symptoms in male asylum seekers and refugees resettled in Italy 54
Deficit severo e persistente delle cellule dendritiche plasmocitoidi nei pazienti con influenza 2009 H1N1 53
Factors Influencing Gestational Age-Adjusted Birthweight in a National Series of 600 Newborns from Mothers with HIV 53
“Episodes of transient HIV viraemia (blips) in HIV-multi-experienced patients: the role of adherence” 52
USE OF DOT IMMUNOBINDING ASSAY (DIB) FOR THE RAPID DIAGNOSIS OF HUMAN BRUCELLOSIS 52
Pregnancy Outcomes in Women with Advanced HIV Infection in Italy 52
Invasive aspergillosis in patients with liver disease 52
"Cellule dendritiche del sangue periferico nel monitoraggio del paziente con infezione da HIV". 47
Increased Carotid Intima Media Thickness Is Associated with Depletion of Circulating Myeloid Dendritic Cells in Patients on Suppressive ART 46
Interleukin-15 in HIV-infection: immunologic and virologic interactions in antiretroviral-naive and –treated patients. 46
Urolithiasis under atazanavir boosted and tenofovir therapy: a case report.J Chemother. 46
In vivo and in vitro effects of antituberculosis treatment on mycobacterial Interferon-gamma T cell response. 46
Interleukin-15 modulates interferon-gamma and beta-chemokine production in patients with HIV infection: implications for immune-based therapy 44
In Vivo Release of Alpha-Defensins in Plasma, Neutrophils and CD8 T-Lymphocytes of Patients with HIV Infection 44
Candidal thrombophlebitis of central veins: case report and review 43
"Interferon-g Release Assays (IGRAs) for Detection and Treatment Response of Tuberculosis in Patients with HIV Infection" 42
IMMUNOBLOT ANALYSIS OF ANTIBODY-RESPONSE TO SALMONELLA SPP AND ESCHERICHIA-COLI LIPOPOLYSACCHARIDES (LPS) IN TYPHOID PATIENTS 42
Intracranial tuberculous mass lesions treated with thalidomide in an immunocompetent child from a low tuberculosis endemic country: A case report 38
Tumour Necrosis Factor-alpha Production and Immune Cell Activation in Tuberculous Meningitis. 36
“Ocular syphilis in an HIV-infected patient: active disease or immune reconstitution syndrome?” 36
"Utilizzo del TDM nella gestione dei pazienti HIV+ in trattamento ARV" 35
Evaluation of the factors associated with reinfections towards SARS-CoV-2 using a case control design 34
HORMONAL STATUS AND NATURAL IMMUNITY IN HIV INFECTED PATIENTS 34
USE OF DOT IMMUNOBINDING ASSAY FOR THE RAPID DIAGNOSIS OF HUMAN HYDATIDOSIS 34
In vitro effect of HIV protease inhibitors on cytokine production 33
“Impaired adipokine profile in HIV positive patients without metabolic syndrome: the role of antiretroviral therapy.” 33
“Campagne informative di prevenzione: l’esperienza dell’ANLAIDS Lazio con i ragazzi delle scuole medie superiori”. 32
Interferon-γ release assay in HIV-infected patients with active tuberculosis: impact of antituberculous drugs on host immune response. 32
Neutralizing antibodies against HIV-1 correlated with non progressive course of infection 29
IMPAIRED ADIPOKINE PROFILE IN HIV POSITIVE PATIENTS: THE ROLE OF BACKBONE 27
PHARMACOLOGICAL MODULATION OF APOPTOSIS OF PBMC BY DARUNAVIR AND MARAVIROC 27
Effect in vitro of CCR5 Antagonists on Innate Immune System: Maraviroc Inhibits the Migration of Neutrophils, Macrophages, and DC 27
Synergistic effect between SARS-CoV-2 wave and COVID-19 vaccination on the occurrence of mild symptoms in healthcare workers 26
Immunoblot analysis of Salmonella typhi lipopolysaccharide (LPS) using typhoid sera. 26
Study of intracellular and immunomodulant effects of CCR5 Antagonist Maraviroc 25
CSF PROTEOLYTIC ACTIVITY AND MRI-DETECTABLE DEMYELINATION IN HIV-1-INFECTED PATIENTS WITH NEUROLOGICAL DISEASES 24
Systemic antibody response to Salmonella typhi lipopolysaccharide in typhoid patients: evaluation by enzyme-linked immunosorbent assay and immunoblotting 24
In vitro downregulation of anti-myelin proteolitic activity by indinavir 23
Elevated levels of tumor necrosis factor (TNF) in the cerebrospinal fluid from patients with HIV-associated neurological disorders. 23
Principi di Terapia antinfettiva 23
Totale 6.051
Categoria #
all - tutte 17.409
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.409


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.278 0 0 0 98 191 251 226 167 143 93 45 64
2020/2021497 49 78 9 96 7 44 20 46 59 62 21 6
2021/20221.140 2 72 93 32 139 22 37 114 126 83 205 215
2022/20231.215 229 250 56 124 129 116 21 90 96 8 64 32
2023/2024648 45 63 27 34 75 114 16 52 14 69 67 72
2024/2025262 63 79 112 8 0 0 0 0 0 0 0 0
Totale 6.227